| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/26/2012 | US20120189554 Multi-functional drug carriers |
| 07/26/2012 | US20120189552 Compositions and methods using microspheres and non-ionic contrast agents |
| 07/26/2012 | US20120189550 Orally administered bacteria as vehicles for systematic delivery of agents |
| 07/26/2012 | US20120189541 Dual Variable Domain Immunnoglobulins and Uses Thereof |
| 07/26/2012 | US20120189540 IL3Ralpha Antibody Conjugates And Uses Thereof |
| 07/26/2012 | US20120189539 Bcl-2/bcl-xl inhibitors and therapeutic methods using the same |
| 07/26/2012 | US20120189537 Nitrile derivatives and their pharmaceutical use and compositions |
| 07/26/2012 | CA2824997A1 Compositions and methods for treating cancer |
| 07/26/2012 | CA2824925A1 Quinazolinone inhibitors of dynein |
| 07/26/2012 | CA2824873A1 Bicyclic carboxamide inhibitors of kinases |
| 07/26/2012 | CA2824871A1 Bicyclic inhibitors of alk |
| 07/26/2012 | CA2824689A1 Combination therapy for cancer |
| 07/26/2012 | CA2824544A1 Picolinamide inhibitors of kinases |
| 07/26/2012 | CA2824332A1 Bicyclic inhibitors of alk |
| 07/26/2012 | CA2823780A1 Novel 4-amino-n-hydroxy-benzamides as hdac inhibitors for the treatment of cancer |
| 07/26/2012 | CA2816093A1 Compounds and compositions for the treatment of cancer |
| 07/25/2012 | EP2479276A1 HLA-A*1101-restricted WT1 peptide and pharmaceutical composition comprising the same |
| 07/25/2012 | EP2479275A1 HLA-A*1101-restricted WT1 peptide and pharmaceutical composition comprising the same |
| 07/25/2012 | EP2479174A1 6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof |
| 07/25/2012 | EP2478907A2 Methods and compositions for treating cancer |
| 07/25/2012 | EP2478905A2 Treatment of imatinib resistant leukemia using 4-aminoquinoline-3-carbonitriles |
| 07/25/2012 | EP2478904A1 A pharmaceutical composition for peroral administration of diindolylmethane |
| 07/25/2012 | EP2478899A1 Composition for alleviating ultraviolet radiation-induced damage |
| 07/25/2012 | EP2477989A1 COMPOUNDS HAVING TAFIa INHIBITORY ACTIVITY |
| 07/25/2012 | EP2477988A1 Acetylene derivatives of 5-phenyl-pyrazolopyridine, preparation thereof, and therapeutic use thereof |
| 07/25/2012 | EP2477975A1 Solid forms of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and methods of making the same |
| 07/25/2012 | EP2477972A1 Abt-263 crystalline forms and solvates for use in treating bcl-2 protein related diseases |
| 07/25/2012 | EP2477700A2 Pharmaceutical compositions which inhibit fkbp52-mediated regulation of androgen receptor function and methods of using same |
| 07/25/2012 | EP2477699A1 Medical use of spla2 hydrolysable liposomes |
| 07/25/2012 | EP2477655A2 Vaccines directed to langerhans cells |
| 07/25/2012 | EP2477653A1 Dosage regimen for administering an epcamxcd3 bispecific antibody |
| 07/25/2012 | EP2477641A2 Inhibition of endosomal toll-like receptor activation |
| 07/25/2012 | EP2477635A2 Methods for treating brain tumors |
| 07/25/2012 | EP2477632A1 Pharmaceutical combination for treating tumor |
| 07/25/2012 | EP2477625A2 Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same |
| 07/25/2012 | EP2477496A1 Novel compounds and therapeutic use thereof for protein kinase inhibition |
| 07/25/2012 | EP2131867B1 Modified hydroxypolymer conjugates with killing effect on tumor cells |
| 07/25/2012 | EP2089401B1 Use of tri-substituted glycerol compounds for the treatment of radiation injuries |
| 07/25/2012 | EP2018170B1 Medication against breast cancer |
| 07/25/2012 | EP2007774B1 Thiazolyldihydroindazole derivatives as protein kinase inhibitors |
| 07/25/2012 | EP1684780B1 The use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin |
| 07/25/2012 | EP1592457B1 Folate-vinblastine conjugate as medicament |
| 07/25/2012 | EP1501921B2 Improved viral purification methods |
| 07/25/2012 | EP1390349B1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands |
| 07/25/2012 | EP1322641B1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases |
| 07/25/2012 | EP1252162B1 Alpha v integrin receptor antagonists |
| 07/25/2012 | EP0800829B2 Use of a pm-1 antibody or of a mh 166 antibody for enhancing the anti-tumor effect of cisplatin or carboplatin |
| 07/25/2012 | CN1872334B Slow releasing microsphere preparation of Thymopentin, and preparation method |
| 07/25/2012 | CN1653183B Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 07/25/2012 | CN102612524A Dual variable domain immunoglobulins and uses thereof |
| 07/25/2012 | CN102612516A Substituted pyrrolidine-2-carboxamides |
| 07/25/2012 | CN102612369A Anti-tumor effect potentiator |
| 07/25/2012 | CN102612368A Method of treating proliferative disorders and other pathological conditions mediated by Bcr-Abl, c-Kit, DDR1, DDR2 or PDGF-R kinase activity |
| 07/25/2012 | CN102612365A Checkpoint kinase 1 inhibitors for potentiating DNA damaging agents |
| 07/25/2012 | CN102604992A Method for constructing recombinant adenovirus by utilizing TRAIL and HN genes as well as recombinant adenovirus and application |
| 07/25/2012 | CN102604970A Preparation method and application of medoggreenpit-viper venom L-amino acid oxidase |
| 07/25/2012 | CN102604952A miRNA molecule and application thereof |
| 07/25/2012 | CN102604949A Anaerobic tissue selective gene expression method driven by alcohol dehydrogenase promoter and application thereof |
| 07/25/2012 | CN102604946A Small interfering ribonucleic acid (siRNA) for inhibiting tumor metastasis and application thereof |
| 07/25/2012 | CN102604855A Bifidobacterium longum SQS7-31, as well as preparation method and application thereof |
| 07/25/2012 | CN102604083A Polymer modified lipid material and application thereof |
| 07/25/2012 | CN102604082A Cis-platinum coordination compound and preparation method thereof |
| 07/25/2012 | CN102603911A Corbicula fluminea glycosaminoglycan and preparation method and usage thereof |
| 07/25/2012 | CN102603909A Laminarin with antioxidation and antineoplastic activity and extracting-separating method of laminarin |
| 07/25/2012 | CN102603897A Fusion protein containing guide peptide and GnRH-PE39KDEL as well as nucleic acid and application thereof |
| 07/25/2012 | CN102603887A IL-24 (interleukin-24) polypeptide with tumor resistance and application thereof |
| 07/25/2012 | CN102603884A Diamond back moth antibacterial peptide and preparation method and application thereof |
| 07/25/2012 | CN102603858A Azacycle-containing derivative of betulinol, preparation method thereof, and purpose thereof |
| 07/25/2012 | CN102603856A Anti-tumor saponin in anemone plants and preparation method thereof as well as application |
| 07/25/2012 | CN102603849A Gynostemma pentaphylla secondary saponin, preparation method and applications thereof |
| 07/25/2012 | CN102603848A Preparation method of ginsenoside Rh2 fatty acid diester, and medicinal use of the ginsenoside Rh2 fatty acid diester |
| 07/25/2012 | CN102603847A Preparation method and medicinal application of ginsenoside Rh2 aliphatic ester compound |
| 07/25/2012 | CN102603826A Method for extracting 8-acetylharpagide from decumbent bugle herb plant |
| 07/25/2012 | CN102603824A New 3'-azido daunorubicin-13-thiosemicarbazone compound with cancer resistance and preparation method thereof |
| 07/25/2012 | CN102603812A Binuclear platinum (II)-zoledronate complex and preparation and application thereof |
| 07/25/2012 | CN102603805A Platinum (II) complex with antineoplastic activity and preparation method of platinum (II) complex |
| 07/25/2012 | CN102603804A Novel platinum complex, preparation method and applications of platinum complex |
| 07/25/2012 | CN102603783A Targeted malignant tumor resistance medicament and preparation method thereof |
| 07/25/2012 | CN102603769A Sulfur-containing chromone compound and preparation method thereof and application in preparation of antitumor drugs |
| 07/25/2012 | CN102603766A Preparation method and application of tamoxifen twin drug |
| 07/25/2012 | CN102603765A Method for extracting active ingredients of Euphorbia fischeriana and diterpenoid medicament prepared by active ingredients |
| 07/25/2012 | CN102603763A Method for extracting lignans compounds from Radix Clematidis and application |
| 07/25/2012 | CN102603761A Etoposide compound with hydroxamic acid structure and preparation method and usage thereof |
| 07/25/2012 | CN102603759A Camptothecin E ring analogues and applications thereof as drugs |
| 07/25/2012 | CN102603753A Isomers of hemoporfin |
| 07/25/2012 | CN102603743A Anti-tumor benzazepine[f]azulene derivative, preparation method thereof, and purpose thereof |
| 07/25/2012 | CN102603737A Pyridopyrimidine ketones derivative and application in preparing antitumor drugs thereof |
| 07/25/2012 | CN102603734A Protein kinase inhibitor and application thereof |
| 07/25/2012 | CN102603729A N-(2-(substituted benzothiazole-2-formamyl)-substituted phenyl) pyridine carboxamide derivative |
| 07/25/2012 | CN102603728A 4-alkyl-2-aryl amino-5-(1,2,4-triazol-1-yl)thiazole and preparation method and application thereof |
| 07/25/2012 | CN102603727A Synthetic method of benzothiazole derivative |
| 07/25/2012 | CN102603717A Pyrrylketone compound and application thereof as drug |
| 07/25/2012 | CN102603712A S-type and R-type tetrahydro-naphthalene amides antitumor compound and pharmaceutically acceptable salt or pro-drug thereof, preparation method and application |
| 07/25/2012 | CN102603692A Chroman and chromene derivatives as tumor multidrug resistance inhibitor as well as preparation method and application of chroman and chromene derivatives |
| 07/25/2012 | CN102603689A Norditerpenoid compound Lachnin A, and preparation method and application thereof |
| 07/25/2012 | CN102603677A Curcumin-4-mannich base derivative, preparation method and use of curcumin-4-mannich base derivative |
| 07/25/2012 | CN102603667A N-(2-chloro-6-methyl phenyl)-2-(phenyl acrylamide)thiazole-5-formamide derivative, and preparation method and use thereof |
| 07/25/2012 | CN102603642A Nickel-containing sandwich polyoxometallate anti-cancer drug and synthesis method thereof |
| 07/25/2012 | CN102603637A Pyrazol compound and purpose of pyrazol compound used as receptor tyrosine kinases (RTK) and phosphatidyl inositol 3-kinase (PI3K) dual inhibitors |
| 07/25/2012 | CN102603635A Derivatives of geldanamycin, as well as preparation method and application thereof |